- Program Integration and Management This P01 grant application consists of four investigator-initiated and led research projects at geographically distinct locations interacting with two core resources constructed around a theme of prostate cancer metastasis. Our P01 joins multi-disciplinary expertise and state-of-the art research projects with commitments from a leading institution to produce successful advances in our understanding of the drivers of prostate cancer metastasis. The projects and cores proposed in this application are highly integrated and are poised to take maximum advantage of the program project grant mechanism to achieve its overall goals. This multi-center structure is both the greatest strength of this P01 and yet is also a challenge. Administration will be especially important in that it will provide the coordinated management structure, allowing each participating institution to interact and communicate effectively. A flexible, highly interactive administrative structure is proposed whereby research plans can be collaboratively developed and progress can be continuously monitored. The overall objective of Program Integration and Management is to provide leadership, direction, coordination, and administrative services for the purposes of enhancing research productivity and maintaining a highly effective research environment. An important goal will be to foster the exchange of ideas and promote collaboration through interactions between the Project Leaders, Core Directors and all members of the research groups. In order to achieve the overall objective, Program Integration & Management will focus on the following primary objectives: 1) Leadership; 2) Site Coordination & Administrative Management; 3) Communications Management and 4) Scientific Oversight. The research environment so created will provide an exceptional opportunity by recasting a potential weakness- the multiple participating institutions - into a significant strength, namely, a remarkably broad and deep coalition of prostate cancer investigators with a demonstrated history of commitment and accomplishment in the study of prostate cancer metastasis.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA098912-12
Application #
9149386
Study Section
Special Emphasis Panel (ZCA1)
Program Officer
Woodhouse, Elizabeth
Project Start
Project End
Budget Start
2016-03-01
Budget End
2017-02-28
Support Year
12
Fiscal Year
2016
Total Cost
Indirect Cost
Name
Cedars-Sinai Medical Center
Department
Type
DUNS #
075307785
City
Los Angeles
State
CA
Country
United States
Zip Code
90048
Tighiouart, Mourad; Cook-Wiens, Galen; Rogatko, André (2018) A Bayesian adaptive design for cancer phase I trials using a flexible range of doses. J Biopharm Stat 28:562-574
Madhav, Anisha; Andres, Allen; Duong, Frank et al. (2018) Antagonizing CD105 enhances radiation sensitivity in prostate cancer. Oncogene 37:4385-4397
Jan, Yu Jen; Chen, Jie-Fu; Zhu, Yazhen et al. (2018) NanoVelcro rare-cell assays for detection and characterization of circulating tumor cells. Adv Drug Deliv Rev 125:78-93
Grindel, Brian J; Martinez, Jerahme R; Tellman, Tristen V et al. (2018) Matrilysin/MMP-7 Cleavage of Perlecan/HSPG2 Complexed with Semaphorin 3A Supports FAK-Mediated Stromal Invasion by Prostate Cancer Cells. Sci Rep 8:7262
Jimenez, Jose L; Tighiouart, Mourad; Gasparini, Mauro (2018) Cancer phase I trial design using drug combinations when a fraction of dose limiting toxicities is attributable to one or more agents. Biom J :
Martinez, Jerahme R; Grindel, Brian J; Hubka, Kelsea M et al. (2018) Perlecan/HSPG2: Signaling role of domain IV in chondrocyte clustering with implications for Schwartz-Jampel Syndrome. J Cell Biochem :
Rohena-Rivera, Krizia; Bhowmick, Neil A (2018) Notch inhibitor screening reveals an unexpected HES1 heterodimer. J Biol Chem 293:8295-8296
Farach-Carson, Mary C; Lin, Sue-Hwa; Nalty, Theresa et al. (2017) Sex Differences and Bone Metastases of Breast, Lung, and Prostate Cancers: Do Bone Homing Cancers Favor Feminized Bone Marrow? Front Oncol 7:163
Stewart, Paul A; Khamis, Zahraa I; Zhau, Haiyen E et al. (2017) Upregulation of minichromosome maintenance complex component 3 during epithelial-to-mesenchymal transition in human prostate cancer. Oncotarget 8:39209-39217
Nandana, Srinivas; Tripathi, Manisha; Duan, Peng et al. (2017) Bone Metastasis of Prostate Cancer Can Be Therapeutically Targeted at the TBX2-WNT Signaling Axis. Cancer Res 77:1331-1344

Showing the most recent 10 out of 215 publications